1-19-2023: Rochester, MN: "bioaccumulation of GS-441524 is postulated to be the cause of remdesivir-induced, cardiovascular conduction abnormalities...this event is more common in those with baseline damaged cardiovascular health" https://t.co/gyWIoeQXhc
Due to cardiac abnormalities observed in some COVID-19 patients treated with #Remdesivir, researchers from @MayoClinic @MayoClinicINFD @albioncollege used a molecular model to investigate the mechanism of action. See the results in @CanadaCSPS title JPPS:
Just published our latest research on #COVID19 and #remdesivir use! Our team used molecular modeling to uncover the potential mechanism behind cardiac conduction abnormalities. @HviUpmc @PittCardiology @UPMC @MayoClinic https://t.co/zudnIZxMgH
2-13-2023: Rochester, MN: Bioelectrical conductivity issues occur with remdesivir's cardiovascular toxicity: https://t.co/epIZkGZ420 https://t.co/EHkbEF7VIw https://t.co/pkgORDRujh https://t.co/fb8J7rl2Wb https://t.co/2Dh26Mncps https://t.co/6uCBpJ9B2c ht